|
27 Aug 2019 |
Adaptimmune and Noile-Immune Announce Agreement to Develop SPEAR T-Cell Products expressing IL-7 and CCL19 as a next-generation treatment for cancer patients
|
|
27 Aug 2019 |
Zogenix Announces Acquisition of Modis Therapeutics, Inc.
|
|
27 Aug 2019 |
Bristol-Myers Squibb Announces Agreement Between Celgene and Amgen to Divest OTEZLA® for $13.4 Billion
|
|
22 Aug 2019 |
Innovent Enters a Licensing Agreement with Lilly to Develop & Commercialize a Novel Diabetes Medicine in China
|
|
20 Aug 2019 |
Alligator Bioscience Signs Antibody Agreement for Greater China with Biotheus Inc.
|
|
20 Aug 2019 |
OKYO Pharma Announces Collaboration with Prof. Pedram Hamrah to Evaluate Proprietary Lead Compounds as Non-Opioid Analgesics Targeting G-Protein Coupled Receptors
|
|
15 Aug 2019 |
Phio Pharmaceuticals and Helmholtz Zentrum München to Collaborate on Novel Targets for the Use of Self-Delivering RNAi In T Cell and NK Cell Adoptive Cell Therapy Therapeutics
|
|
14 Aug 2019 |
Ultragenyx Announces Partnership with GeneTx to Advance Treatment for Angelman Syndrome
|
|
13 Aug 2019 |
AskBio Acquires Synpromics Ltd. and Expands its Gene Therapy Technology Portfolio
|
|
13 Aug 2019 |
Jazz Pharmaceuticals Announces Acquisition of Cavion, Inc.
|
|
13 Aug 2019 |
Pharming acquires exclusive license to CDZ173, a late stage drug for the treatment of APDS
|
|
12 Aug 2019 |
Boehringer Ingelheim and MD Anderson form unique Virtual Research and Development Center to rapidly advance new cancer therapies
|
|
12 Aug 2019 |
RELIEF THERAPEUTICS Holding SA Announces Divestment of its Subsidiary Relief Therapeutics SA to Sonnet BioTherapeutics, Inc. to Ensure the Development of Atexakin Alpha (Interleukin-6)
|
|
12 Aug 2019 |
AC Immune Announces Research Collaboration with University of Pennsylvania Focusing on Pathogenic Protein TDP-43 in Neurodegenerative Diseases
|
|
08 Aug 2019 |
Bayer acquires BlueRock Therapeutics to build leading position in cell therapy
|
|
06 Aug 2019 |
Aquinox Pharmaceuticals and Neoleukin Therapeutics announce merger agreement
|
|
05 Aug 2019 |
Neuropore Therapies and BenevolentAI Enter Strategic Collaboration to Discover Novel Therapeutics Through the Application of Artificial Intelligence
|
|
05 Aug 2019 |
Sosei Heptares and Takeda Enter Into New Strategic Multi-target Research, Development and Commercialization Partnership
|
|
01 Aug 2019 |
ImCheck Therapeutics Awarded €2 Million From Bpifrance to Advance its First-in-class Immunotherapy Program Into the Clinic
|
|
01 Aug 2019 |
Rewind Therapeutics Awarded €2.9 Million VLAIO Grant to Discover and Develop Novel Drug Candidates for Myelin-related Neurological Diseases
|
|
01 Aug 2019 |
Exelixis and Aurigene Enter Into Exclusive Collaboration, Option and License Agreement to Discover and Develop Novel Therapies for Cancer
|
|
31 Jul 2019 |
REGENXBIO Announces New License Agreement with Pfizer for the Treatment of Friedreich's Ataxia Using NAV® AAV9 Vector
|
|
31 Jul 2019 |
Alizé Pharma 3 raises €67 million ($75 million) in Series A from a strong international syndicate
|
|
29 Jul 2019 |
Mylan and Upjohn, a Division of Pfizer, to Combine, Creating a New Champion for Global Health Uniquely Positioned to Fulfill the World’s Need for Medicine
|
|
27 Jul 2019 |
Zambon completes transformational acquisition of Breath Therapeutics
|
